Skip to main content
Premium Trial:

Request an Annual Quote

Warnex Inks Deal with Canada to Develop Forensic Mitochondrial Pre-screen

NEW YORK (GenomeWeb News) – Warnex Pro-DNA Services today announced a contribution agreement with Canada's federal research and development organization to develop a pre-screening method for forensic mitochondrial DNA testing.

Under the deal, the National Research Council of Canada Industrial Research Assistance Program will provide Warnex Pro-DNA up to C$49,200 (US$48,000) in funding, as well as technical and business advisory services.

Based in Thunder Bay, Ontario, Warnex Pro-DNA is a subsidiary of Warnex, and is the only private Canadian laboratory offering short tandem repeat (STR), Y-STR, miniSTR, mitochondrial DNA, and its Pro-DNA Lead testing services for forensic testing applications, it said. Mitochondrial DNA testing, it added, is "crucial" in cases in which nuclear DNA testing cannot be done, including shed hair at crime scenes, degraded DNA in skeletal remains, and when there are insufficient amounts of nuclear DNA.

The method that Warnex Pro-DNA is developing "will provide a fast, accurate, and inexpensive way to screen crime scene samples, such as fingerprint lifts, and touch DNA samples for mitochondrial DNA analysis," Mark Busgang, president and CEO of Warnex, said in a statement.

The Scan

Test of the China Initiative

According to Science, the upcoming trial of Harvard University chemist Charles Lieber will test the US China Initiative.

Collaborative Approach

A virologist who spotted the Omicron variant of SARS-CoV-2 tells the Associated Press that its detection was aided by scientific sharing.

Genes of a Guide Dog

Wired reports on a study aimed at uncovering genes involved in being a successful guide dog.

PLOS Papers on RNAs in Metastatic Prostate Cancer, Ebola Field Lab, Embryonic RNA Editing

In PLOS this week: circRNA-mediated ceRNA network points to prostate cancer biomarkers, Ebola testing at frontline field laboratory, and more.